164 related articles for article (PubMed ID: 11374316)
1. The role of adjuvant chemotherapy for locally advanced bladder cancer.
Lehmann J; Retz M; Stöckle M
World J Urol; 2001 Apr; 19(2):133-40. PubMed ID: 11374316
[TBL] [Abstract][Full Text] [Related]
2. Chemotherapy in the post-MVAC era: the case for adjuvant chemotherapy.
Lehmann J; Retz M; Stöckle M
World J Urol; 2002 Aug; 20(3):144-50. PubMed ID: 12196897
[TBL] [Abstract][Full Text] [Related]
3. Results of radical cystectomy for transitional cell carcinoma of the bladder and the effect of chemotherapy.
Soloway MS; Lopez AE; Patel J; Lu Y
Cancer; 1994 Apr; 73(7):1926-31. PubMed ID: 8137219
[TBL] [Abstract][Full Text] [Related]
4. Neoadjuvant M-VAC (methotrexate, vinblastine, doxorubicin, and cisplatin) for infiltrating transitional cell carcinoma of the bladder.
Sternberg CN; Arena MG; Calabresi F; De Carli P; Platania A; Zeuli M; Giannarelli D; Cancrini A; Pansadoro V
Cancer; 1993 Sep; 72(6):1975-82. PubMed ID: 8364877
[TBL] [Abstract][Full Text] [Related]
5. Neoadjuvant chemotherapy plus cystectomy compared with cystectomy alone for locally advanced bladder cancer.
Grossman HB; Natale RB; Tangen CM; Speights VO; Vogelzang NJ; Trump DL; deVere White RW; Sarosdy MF; Wood DP; Raghavan D; Crawford ED
N Engl J Med; 2003 Aug; 349(9):859-66. PubMed ID: 12944571
[TBL] [Abstract][Full Text] [Related]
6. Radical cystectomy with or without adjuvant polychemotherapy for non-organ-confined transitional cell carcinoma of the urinary bladder: prognostic impact of lymph node involvement.
Stöckle M; Wellek S; Meyenburg W; Voges GE; Fischer U; Gertenbach U; Thüroff JW; Huber C; Hohenfellner R
Urology; 1996 Dec; 48(6):868-75. PubMed ID: 8973669
[TBL] [Abstract][Full Text] [Related]
7. Adjuvant chemotherapy for locally advanced urothelial carcinoma: an overview of the USC experience.
Dorff TB; Tsao-Wei D; Miranda G; Skinner DG; Stein JP; Quinn DI
World J Urol; 2009 Feb; 27(1):39-44. PubMed ID: 19020886
[TBL] [Abstract][Full Text] [Related]
8. Can patient selection for bladder preservation be based on response to chemotherapy?
Sternberg CN; Pansadoro V; Calabrò F; Schnetzer S; Giannarelli D; Emiliozzi P; De Paula F; Scarpone P; De Carli P; Pizzo M; Platania A; Amini M
Cancer; 2003 Apr; 97(7):1644-52. PubMed ID: 12655521
[TBL] [Abstract][Full Text] [Related]
9. Complete long-term survival data from a trial of adjuvant chemotherapy vs control after radical cystectomy for locally advanced bladder cancer.
Lehmann J; Franzaring L; Thüroff J; Wellek S; Stöckle M
BJU Int; 2006 Jan; 97(1):42-7. PubMed ID: 16336326
[TBL] [Abstract][Full Text] [Related]
10. Neoadjuvant methotrexate, vinblastine, doxorubicin and cisplatin for histologically proven lymph node positive bladder cancer.
Nieuwenhuijzen JA; Bex A; Meinhardt W; Kerst JM; Schornagel JH; VAN Tinteren H; Horenblas S
J Urol; 2005 Jul; 174(1):80-5. PubMed ID: 15947583
[TBL] [Abstract][Full Text] [Related]
11. Methotrexate, vinblastine, doxorubicin and cisplatin chemotherapy and cystectomy for unresectable bladder cancer.
Donat SM; Herr HW; Bajorin DF; Fair WR; Sogani PC; Russo P; Sheinfeld J; Scher I
J Urol; 1996 Aug; 156(2 Pt 1):368-71. PubMed ID: 8683681
[TBL] [Abstract][Full Text] [Related]
12. Adjuvant polychemotherapy of nonorgan-confined bladder cancer after radical cystectomy revisited: long-term results of a controlled prospective study and further clinical experience.
Stöckle M; Meyenburg W; Wellek S; Voges GE; Rossmann M; Gertenbach U; Thüroff JW; Huber C; Hohenfellner R
J Urol; 1995 Jan; 153(1):47-52. PubMed ID: 7966789
[TBL] [Abstract][Full Text] [Related]
13. Retrospective analysis of the efficacy of two cycles of M-VAC neoadjuvant chemotherapy followed by radical cystectomy for muscle-invasive bladder cancer.
Kitagawa Y; Izumi K; Miwa S; Kadono Y; Konaka H; Mizokami A; Namiki M
Anticancer Res; 2013 Oct; 33(10):4497-503. PubMed ID: 24123021
[TBL] [Abstract][Full Text] [Related]
14. Adjuvant and neoadjuvant chemotherapy for invasive bladder cancer.
Kuroda M; Meguro N; Maeda O; Saiki S; Kinouchi T; Usami M; Kotake T
Cancer Chemother Pharmacol; 1994; 35 Suppl():S9-13. PubMed ID: 7527736
[TBL] [Abstract][Full Text] [Related]
15. Neo-adjuvant and adjuvant treatment of locally invasive bladder cancer.
Schultz-Lampel D; Lampel A
Curr Opin Urol; 1999 Sep; 9(5):419-24. PubMed ID: 10579080
[TBL] [Abstract][Full Text] [Related]
16. Adjuvant chemotherapy for deep muscle-invasive transitional cell bladder carcinoma - a practice guideline.
Segal R; Winquist E; Lukka H; Chin JL; Brundage M; Markman BR;
Can J Urol; 2002 Oct; 9(5):1625-33. PubMed ID: 12431323
[TBL] [Abstract][Full Text] [Related]
17. Neoadjuvant chemotherapy for invasive bladder carcinoma: disease outcome and bladder preservation and relationship to local tumor response.
Hatcher PA; Hahn RG; Richardson RL; Zincke H
Eur Urol; 1994; 25(3):209-15. PubMed ID: 8200403
[TBL] [Abstract][Full Text] [Related]
18. [Prognosis in pT3b infiltrating tumors of the bladder treated by adjuvant chemotherapy].
Sahwi A; Robert M; Delbos O; Legouffe E; Guiter J; Navratil H
Prog Urol; 1998 Dec; 8(6):1007-11. PubMed ID: 9894259
[TBL] [Abstract][Full Text] [Related]
19. [The prognostic value of adjuvant and neoadjuvant chemotherapy in total cystectomy for locally advanced bladder cancer].
Habuchi T; Kakehi Y; Terachi T; Ogawa O; Yoshida O
Nihon Hinyokika Gakkai Zasshi; 1999 Oct; 90(10):809-17. PubMed ID: 10565159
[TBL] [Abstract][Full Text] [Related]
20. The effect of cystectomy, and perioperative methotrexate, vinblastine, doxorubicin and cisplatin chemotherapy on the risk and pattern of relapse in patients with muscle invasive bladder cancer.
Ennis RD; Petrylak DP; Singh P; Bagiella E; O'Toole KM; Benson MC; Olsson CA
J Urol; 2000 May; 163(5):1413-8. PubMed ID: 10751847
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
